Repligen Corporation (RGEN)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -25,514 | 41,577 | 185,959 | 128,291 | 59,926 |
| Total stockholders’ equity | US$ in thousands | 1,972,720 | 1,971,200 | 397,272 | 1,750,070 | 65,769 |
| ROE | -1.29% | 2.11% | 46.81% | 7.33% | 91.12% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $-25,514K ÷ $1,972,720K
= -1.29%
Repligen Corporation's return on equity (ROE) has shown fluctuations over the years. In 2020, the ROE was strong at 91.12%, indicating that the company generated a high return for each dollar of shareholder equity. However, by the end of 2021, the ROE dropped significantly to 7.33%, suggesting a decline in the efficiency of the company in utilizing its equity to generate profits.
In 2022, the ROE improved to 46.81%, indicating a rebound in the company's profitability. This increase could be attributed to improved operational performance or strategic decisions that enhanced shareholder value. However, in 2023, the ROE dropped sharply to 2.11%, signaling a decline in the company's profitability and efficiency in generating returns for shareholders.
By the end of 2024, Repligen Corporation experienced a negative ROE of -1.29%, which implies that the company incurred losses that exceeded the equity investments made by shareholders. This negative ROE may raise concerns about the company's financial health and operational performance.
Overall, Repligen Corporation's ROE has been volatile, with periods of strong performance followed by declines and even negative returns. Investors and analysts may need to closely monitor the company's financial indicators and strategies to assess its ability to deliver consistent and sustainable returns on equity in the future.
Peer comparison
Dec 31, 2024